86 related articles for article (PubMed ID: 25666914)
1. β-Thujaplicin modulates estrogen receptor signaling and inhibits proliferation of human breast cancer cells.
Ko J; Bao C; Park HC; Kim M; Choi HK; Kim YS; Lee HJ
Biosci Biotechnol Biochem; 2015; 79(6):1011-7. PubMed ID: 25666914
[TBL] [Abstract][Full Text] [Related]
2. β-Thujaplicin inhibits basal-like mammary tumor growth by regulating glycogen synthase kinase-3β/β-catenin signaling.
Chen J; Ko J; Kim JT; Cho JS; Qiu S; Kim GD; Auh JH; Lee HJ
Food Funct; 2019 May; 10(5):2691-2700. PubMed ID: 31026007
[TBL] [Abstract][Full Text] [Related]
3. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
4. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of β-thujaplicin against UVB-induced MMP-1 and MMP-3 mRNA expressions in skin fibroblasts.
Cherng JY; Chen LY; Shih MF
Am J Chin Med; 2012; 40(2):387-98. PubMed ID: 22419431
[TBL] [Abstract][Full Text] [Related]
7. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
8. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
9. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
11. Everolimus induces G
Chen G; Ding XF; Bouamar H; Pressley K; Sun LZ
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C244-C252. PubMed ID: 31116586
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/β-Catenin Signaling Pathways.
Mandal A; Bishayee A
Molecules; 2015 Dec; 20(12):22315-28. PubMed ID: 26703530
[TBL] [Abstract][Full Text] [Related]
13. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model.
Yu X; Luo Y; Zhou Y; Zhang Q; Wang J; Wei N; Mi M; Zhu J; Wang B; Chang H; Tang Y
Int J Oncol; 2008 Sep; 33(3):555-63. PubMed ID: 18695886
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
16. A novel antioestrogen agent (3R,6R)-bassiatin inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression in 17β-oestradiol-treated MCF-7 cells.
Meng L; Feng B; Tao H; Yang T; Meng Y; Zhu W; Huang C
Cell Biol Int; 2011 Jun; 35(6):599-605. PubMed ID: 21241249
[TBL] [Abstract][Full Text] [Related]
17. The furan route to tropolones: probing the antiproliferative effects of β-thujaplicin analogs.
Oblak EZ; Bolstad ES; Ononye SN; Priestley ND; Hadden MK; Wright DL
Org Biomol Chem; 2012 Nov; 10(43):8597-604. PubMed ID: 23032214
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of beta-thujaplicin on ultraviolet B-induced apoptosis in mouse keratinocytes.
Baba T; Nakano H; Tamai K; Sawamura D; Hanada K; Hashimoto I; Arima Y
J Invest Dermatol; 1998 Jan; 110(1):24-8. PubMed ID: 9424082
[TBL] [Abstract][Full Text] [Related]
19. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells.
Sengupta S; Kundu S; Bhattacharyya A
Cell Biol Int; 2013 May; 37(5):449-57. PubMed ID: 23494890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
